UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

Hepatology (Baltimore, Md.), 2015-03, Vol.61 (3), p.790-801

2015

Volltextzugriff (PDF)

Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling

Viruses, 2023-02, Vol.15 (3), p.632

2023

Volltextzugriff (PDF)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection

BMC infectious diseases, 2020-12, Vol.20 (1), p.929-9, Article 929

2020

Volltextzugriff (PDF)

Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies

Viruses, 2021-06, Vol.13 (6), p.1090

2021

Volltextzugriff (PDF)

Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study

BMC health services research, 2022-05, Vol.22 (1), p.623-623, Article 623

2022

Volltextzugriff (PDF)

Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration

AIDS research and human retroviruses, 2016-05, Vol.32 (5), p.456

2016

Volltextzugriff (PDF)

Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin

Journal of antimicrobial chemotherapy, 2015-08, Vol.70 (8), p.2322-2329

2015

Volltextzugriff (PDF)

Disseminated microsporidiosis in an immunosuppressed patient

Emerging infectious diseases, 2012-07, Vol.18 (7), p.1155-1158

2012

Volltextzugriff (PDF)

The Gut-Liver Axis in Hepatitis C Virus Infection: A Path Towards Altering the Natural History of Fibrosis Progression?

Clinical infectious diseases, 2018-08, Vol.67 (6), p.878-880

Meissner, Eric G

2018

Volltextzugriff (PDF)

Update in HIV–hepatitis C virus coinfection in the direct acting antiviral era

Current opinion in gastroenterology, 2017-05, Vol.33 (3), p.120-127

Meissner, Eric G

2017

Volltextzugriff (PDF)

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection

Hepatology communications, 2017-09, Vol.1 (7), p.586-594

2017

Volltextzugriff (PDF)

Implementation of free-draft text messaging to enhance care retention and satisfaction for persons living with HIV infection

AIDS care, 2024-04, Vol.36 (4), p.452-462

2024

Volltextzugriff (PDF)

IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling

The Journal of immunology (1950), 2017-12, Vol.199 (11), p.3808-3820

2017

Volltextzugriff (PDF)

Outcomes of discordant HIV screening test results at a southern academic medical center

AIDS (London), 2024-07, Vol.38 (8), p.1181

2024

Volltextzugriff (PDF)

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

The Journal of clinical investigation, 2014-08, Vol.124 (8), p.3352-3363

2014

Volltextzugriff (PDF)

Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035

JNCI : Journal of the National Cancer Institute, 2024-06

2024

Volltextzugriff (PDF)

Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection

JAMA : the journal of the American Medical Association, 2015-03, Vol.313 (12), p.1232

2015

Volltextzugriff (PDF)

Interferon lambda receptor-1 isoforms differentially influence gene expression and HBV replication in stem cell-derived hepatocytes

Antiviral research, 2024-01, Vol.221, p.105779-105779, Article 105779

2024

Volltextzugriff (PDF)

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2013-08, Vol.310 (8), p.804

2013

Volltextzugriff (PDF)

Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection

Liver international, 2020-07, Vol.40 (7), p.1693-1700

2020

Volltextzugriff (PDF)

Association of mental health symptoms on HIV care outcomes and retention in treatment

General hospital psychiatry, 2023-05, Vol.82, p.41-46

2023

Volltextzugriff (PDF)

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies

PLoS pathogens, 2007-08, Vol.3 (8), p.e117-e117

2007

Volltextzugriff (PDF)

The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env

Journal of Virology, 2009-11, Vol.83 (22), p.11715-11725

2009

Volltextzugriff (PDF)

Cardiovascular Disease, Statins, and HIV

The Journal of infectious diseases, 2016-10, Vol.214 (suppl 2), p.S83-S92

2016

Volltextzugriff (PDF)

Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirin

Journal of viral hepatitis, 2019-03, Vol.26 (3), p.323-328

2019

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(67)
Humans
(52)
Female
(27)
Male
(26)
Infectious Diseases
(23)
Middle Aged
(22)
Hepatitis C Virus
(21)
Hiv
(17)
Immunology
(17)
Virology
(17)
Adult
(16)
Hepatitis C, Chronic - Drug Therapy
(16)
Microbiology
(15)
Biological And Medical Sciences
(14)
Infections
(14)
Hepatitis
(13)
Animals
(12)
Antiviral Agents
(12)
Antiviral Agents - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection

Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies

Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study

Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration

Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin

Disseminated microsporidiosis in an immunosuppressed patient

The Gut-Liver Axis in Hepatitis C Virus Infection: A Path Towards Altering the Natural History of Fibrosis Progression?

Update in HIV–hepatitis C virus coinfection in the direct acting antiviral era

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection

Implementation of free-draft text messaging to enhance care retention and satisfaction for persons living with HIV infection

IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling

Outcomes of discordant HIV screening test results at a southern academic medical center

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035

Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection

Interferon lambda receptor-1 isoforms differentially influence gene expression and HBV replication in stem cell-derived hepatocytes

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial

Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection

Association of mental health symptoms on HIV care outcomes and retention in treatment

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies

The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env

Cardiovascular Disease, Statins, and HIV

Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirin

Suchergebnisse filtern